1) and has established itself as an innovator in oncology, dedicated to improving the lives of people with cancer. Novocure milestones in brain cancer treatment. Novocure was founded in 2000 with a patient-forward approach that remains the centre of its corporate mission. The timeline highlights...
"Upon initial diagnosis, glioblastoma patients undergo aggressive treatment, including surgery to remove the tumour, radiation therapy and chemotherapy. However, cancer relapses in less than seven months, resulting in less than 15 months overall median survival," he said. "Almost all the glioblastoma ...
Every cancer comes from a normal cell. The hard part is finding the cell at the root of each particular subtype of cancer. For the first time, the Duke team has identified two types of cells in the brain that can give rise to the malignant brain tumor medulloblastoma. This dangerous cance...
Glioblastoma is an extremely aggressive brain tumour that is currently incurable. Cancer doctors can increase their patients’ life expectancy with surgeries, radiation, chemotherapy, or surgical procedures. Nonetheless, half of patients die within a year of diagnosis. Medications that are effective ag...
More than 80% of patients diagnosed with lung cancer, for example, present with metastatic disease. Nanotechnology is not alien to the clinic; more than 40 nanotherapeutics have reached patients, including anticancer drugs and imaging agents. Many current therapies are not reaching the sites of ...
Nanotechnology offers many opportunities for enhanced diagnostic and therapeutic medicine against cancer and other diseases. In this review, the special pr
Calcium content being equal to 1.1-1.2 mmole/l before chemotherapy and to 0.9-0.95 mmole/l after chemotherapy on auto liquor, the treatment is considered to be effective.;EFFECT: observable positive clinical dynamics of intracerebral malignant process enabling one to select optimal treatment tactics...
The most common primary for brain metastases is lung; in the US in 1992, for example, ther... RJ Andrews,DS Gluck,RH Konchingeri - 《Acta Neurochirurgica》 被引量: 95发表: 1996年 Response of Brain Metastases from Lung Cancer to Systemic Chemotherapy with Carboplatin and Etoposide 30 ...
We’re getting into this space where many patients with bladder cancer will have chemotherapy, then a checkpoint inhibitor, either upon progression on chemotherapy or as maintenance, and then a decision has to be made of what they’ll get next. That’s a situation where there are probably mul...
of Medicine and director of the Breast Oncology Clinical Trials Program at the University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses what sets abemaciclib apart from other CDK 4/6 inhibitors in the field of hormone receptor (HR)-positive breast cancer....